Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Current Hematologic Malignancy Reports|February 23, 2016
Practical Approaches to the Management of Dual Refractory Multiple MyelomaHans C Lee, Tomer M Mark, Jatin J Shah
Clinical Case Reports|October 3, 2022
Lenalidomide-induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosisStephanie Lakritz, Peter A Forsberg, Daniel W Sherbenou, et al.
Frontiers in Immunology|November 13, 2023
Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitorsAdam F Binder, Christopher J Walker, Tomer M Mark, et al.
Frontiers in Oncology|July 11, 2022
Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic ParadigmAlana L Keller, Daniel W Sherbenou, Peter A Forsberg, et al.
Frontiers in Oncology|October 8, 2025
Lower dose and weekly schedules of selinexor in multiple myeloma - updated evidence on safety and efficacyMuhamed Baljevic, Gary Schiller, Tomer M Mark, et al.
Case Reports in Oncological Medicine|November 21, 2015
Diaphragmatic Amyloidosis Causing Respiratory Failure: A Case Report and Review of LiteratureAleksey Novikov, Horatio Holzer, Robert A DeSimone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 8, 2015
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell TransplantationMichael J Satlin, Santosh Vardhana, Rosemary Soave, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 5, 2013
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myelomaTomer M Mark, Whitney Reid, Ruben Niesvizky, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
CDK4/6 Inhibition Reverses MEIS2 Suppression of CRL4 CRBN to Enhance Immunomodulatory Drug Therapy in Multiple MyelomaXiangao Huang, David Jayabalan, Maurizio Di Liberto, et al.
Blood Advances|February 23, 2019
Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myelomaTomer M Mark, Peter A Forsberg, Adriana C Rossi, et al.
Pageof 5